Nanotechnology for blood test to predict the blood diseases/blood disorders

2022 ◽  
pp. 285-311
Author(s):  
Setti Sudharsan Meenambiga ◽  
Punniavan Sakthiselvan ◽  
Sowmya Hari ◽  
Devasena Umai
2020 ◽  
Vol 65 (8) ◽  
pp. 487-491
Author(s):  
O. V. Gaisenok

The aim of this study was to investigate RDW variability and conduct a comparative analysis of the RDW level in patients depending on their belonging to a defined nosological group of diseases according to the ICD-10 classification. All patients who complete blood count tests in our hospital from January to December 2016 were included in the study. The identification of the patient’s belonging to a specific nosological group according to the ICD-10 classification was carried out on the basis of the disease analysis code indicated in the direction of the blood test. 8056 patient records were included in the final analysis. Deviations beyond the upper reference range for the RDW indicator (> 14.5%) in this study were identified for patients of the following nosological groups according to ICD-10: C - neoplasms; D - blood diseases; S - injuries; T - poisoning. Significant intergroup differences were obtained according to the Kruskal-Wallis rank analysis of variance (Kruskal-Wallis test: H (19, n= 7622) = 214.9672 p = 0.0000). According to the results of this study, we can conclude that RDW has specificity for certain diseases (neoplasms; blood diseases; injuries; poisoning). In case of cardiovascular and other diseases, deviations of this indicator beyond the limits of the upper reference values were not found in this study.


Blood ◽  
2018 ◽  
Vol 131 (24) ◽  
pp. 2617-2620 ◽  
Author(s):  
Sophie Paczesny ◽  
Steven Z. Pavletic ◽  
Catherine M. Bollard

Abstract Immune therapies are fast becoming paradigm-changing treatment options for patients with hematologic cancers. The field has grown exponentially as it expands to nonmalignant blood diseases. This Perspective article introduces the review series describing some of the latest advances in this field and highlighting some of the current obstacles and new opportunities for the future. Specifically, the series provides in-depth discussion on a selection of emerging immunotherapies now available to patients for hematologic diseases, including cancer vaccines, chimeric antigen receptor T cells, and immunotherapies to regulate inflammation in nonmalignant blood disorders.


Author(s):  
L. Yu. Zyubina ◽  
L. A. Panacheva ◽  
L. A. Shpagina ◽  
N. P. Kareva ◽  
O. S. Kotova ◽  
...  

The article presents evolutionary changes in occupationally related nonspecific and specific hematologic syndromes, occupational chronic intoxications and blood diseases due to contact with various occupational hazards mostly hematotropic ones, depending on length of service. The presented hematologic characteristics cover specific occupationally related microelement disorders and occupational chronic intoxications during primary diagnosis and in post-contact period. Findings areless occupational chronic chemical intoxications and blood disorders due to hematotropic occupational influences.


2019 ◽  
Vol 14 (1) ◽  
pp. 20-30 ◽  
Author(s):  
P. A. Zharkov ◽  
D. S. Morozova ◽  
D. A. Gobadze ◽  
D. A. Evstratov ◽  
D. V. Fedorova ◽  
...  

Background.Children and adolescents undergoing treatment in the hospital for blood diseases are at risk of thrombotic complications. However, to date no major studies of the prevalence of thrombosis in this category of patients have been conducted in Russia.The objective:to determine the incidence of symptomatic and asymptomatic deep vein thrombosis (DVT), as well as their distribution by gender and age in children with various blood disorders.Materials and methods.Medical records of 1962 patients, aged from 0 to 17 years, were retrospectively analyzed. All DVT cases were confirmed by visualization methods. The presence of thrombosis clinical signs detected during physical examination, allowed identifying symptomatic DVT.Results.DVT was diagnosed in 429 patients; the symptomatic (n = 110) and asymptomatic (n = 337) DVT were considered as two independent groups with cases of thrombosis. The highest incidence of thrombotic complications was found in children with acute lymphoblastic leukemia (ALL) – 30.77 %, non-Hodgkin’s lymphomas – 22.58 %, other malignant blood disorders – 18.75 %, myeloid leukemia – 15.63 %, Hodgkin’s lymphoma – 16.50 %, histiocytosis – 12.5 %, aplastic anemia – 7.94 %, other leukemia – 7.14 %. Symptomatic episodes were more common in patients with lymphomas, especially non-Hodgkin’s, and ALL, while asymptomatic DVT were more common among children with ALL.Conclusion.The DVT prevalence in children with blood disorders exceeds 20 %, most of them are asymptomatic thrombosis, while symptomatic DVT are much less common. Patients receiving treatment for lymphomas and ALL have the highest number of venous thrombotic complications. Further research is needed to address the need for primary thrombotic prophylaxis in children with blood disorders.


2021 ◽  
Vol 22 (19) ◽  
pp. 10475
Author(s):  
Yuhan Zhang ◽  
Mengying Chen ◽  
Caiyong Chen

Vertebrates generate mature red blood cells (RBCs) via a highly regulated, multistep process called erythropoiesis. Erythropoiesis involves synthesis of heme and hemoglobin, clearance of the nuclei and other organelles, and remodeling of the plasma membrane, and these processes are exquisitely coordinated by specific regulatory factors including transcriptional factors and signaling molecules. Defects in erythropoiesis can lead to blood disorders such as congenital dyserythropoietic anemias, Diamond–Blackfan anemias, sideroblastic anemias, myelodysplastic syndrome, and porphyria. The molecular mechanisms of erythropoiesis are highly conserved between fish and mammals, and the zebrafish (Danio rerio) has provided a powerful genetic model for studying erythropoiesis. Studies in zebrafish have yielded important insights into RBC development and established a number of models for human blood diseases. Here, we focus on latest discoveries of the molecular processes and mechanisms regulating zebrafish erythropoiesis and summarize newly established zebrafish models of human anemias.


2008 ◽  
Vol 39 (5) ◽  
pp. 1-8
Author(s):  
BRUCE JANCIN
Keyword(s):  

2005 ◽  
Vol 38 (1) ◽  
pp. 16
Author(s):  
BRUCE JANCIN
Keyword(s):  

2010 ◽  
Vol 43 (13) ◽  
pp. 61
Author(s):  
SARA FREEMAN
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document